Lawsonline™  Directory  Expert Witness  Oncology

Private Consultant in Chemical Toxicology and Chemical Carcinogenesis
Altadena, California
1009 E. Mendocino St, 91001


Contact:  Joseph Richard Landolph, Jr, Ph.D.
Private Consultant in Chemical Toxicology and Chemical Carcinogenesis WEBSITE
323-224-7781 Or Toll Free
joseph.landolph@med.usc.edu
1009 E. Mendocino St
Altadena, California 91001

Contact:  Joseph Richard Landolph, Jr, Ph.D.
Private Consultant in Chemical Toxicology and Chemical Carcinogenesis WEBSITE
323-224-7781
joseph.landolph@med.usc.edu
Cell: 626-993-4397. Joseph R. Landolph, Jr., Ph. D., received B. S. in Chem. from Drexel Univ., Phila., Pa., l971, and Ph. D. in Chemistry from Univ. of Calif. Berkeley, l976, where he studied BaP metabolism and cytotoxicity in mouse liver epithelial/fibroblastic cells. He performed postdoctoral study in chemical carcinogenesis (l977-1980) at the University of Southern California (USC). He was appointed Asst. Prof. of Microbiology/Pathology in l982, and is now Assoc. Prof. of Molecular Microbiology and Immunology/Pathology and Member, USC Cancer Center, Keck School of Medicine, USC. His research interests include carcinogenicity of Ni/Cr compounds, activation of oncogenes/inactivation of tumor suppressor genes, and de-regulation of gene expression, in Ni/Cr carcinogenesis. He is an expert in chemically induced mutation/neoplastic transformation of mammalian cells. He authored 61 scientific publications, gave 190 invited scientific lectures, and trained 20 M. S. students, 11 Ph. D. students and 30 postdoctoral fellows. He reviewed research grants for the US EPA, NIEHS, Chem. Pathol./AlTx-4 Study Sections, NIH; served as a member of Carcinogen Ident. Comm., Calif. EPA (1994-Present); Sci. Rev. Panel for Toxic Air Contaminants, Calif. Air Resour. Brd. (2003-2011); Drinking Water (2003-2009) and Human Health Res. (2003) Committees of US EPA’s Science Advisory Board; NAS Panel on U. S. EPA’s PCE Risk Assessment (2009-2010). He received the Merck Award in Chemistry (Drexel Univ.); an American Cancer Society Postdoctoral Fellowship; an Edmundson Teaching Award (Dept. Path., USC); and a Traveling Lectureship Award (Soc. Tox.). He has held research grants from EPA, NCI, NIEHS. He serves as a part-time Consultant/Expert Witness in Chemical Toxicology and Chemical Carcinogenesis.
Information:  
Hazardous Materials,  Oncology,  Toxic Exposures,  Toxic Tort,  Toxicology, 


Cell: 626-993-4397. Joseph R. Landolph, Jr., Ph. D., received B. S. in Chem. from Drexel Univ., Phila., Pa., l971, and Ph. D. in Chemistry from Univ. of Calif. Berkeley, l976, where he studied BaP metabolism and cytotoxicity in mouse liver epithelial/fibroblastic cells. He performed postdoctoral study in chemical carcinogenesis (l977-1980) at the University of Southern California (USC). He was appointed Asst. Prof. of Microbiology/Pathology in l982, and is now Assoc. Prof. of Molecular Microbiology and Immunology/Pathology and Member, USC Cancer Center, Keck School of Medicine, USC. His research interests include carcinogenicity of Ni/Cr compounds, activation of oncogenes/inactivation of tumor suppressor genes, and de-regulation of gene expression, in Ni/Cr carcinogenesis. He is an expert in chemically induced mutation/neoplastic transformation of mammalian cells. He authored 61 scientific publications, gave 190 invited scientific lectures, and trained 20 M. S. students, 11 Ph. D. students and 30 postdoctoral fellows. He reviewed research grants for the US EPA, NIEHS, Chem. Pathol./AlTx-4 Study Sections, NIH; served as a member of Carcinogen Ident. Comm., Calif. EPA (1994-Present); Sci. Rev. Panel for Toxic Air Contaminants, Calif. Air Resour. Brd. (2003-2011); Drinking Water (2003-2009) and Human Health Res. (2003) Committees of US EPA’s Science Advisory Board; NAS Panel on U. S. EPA’s PCE Risk Assessment (2009-2010). He received the Merck Award in Chemistry (Drexel Univ.); an American Cancer Society Postdoctoral Fellowship; an Edmundson Teaching Award (Dept. Path., USC); and a Traveling Lectureship Award (Soc. Tox.). He has held research grants from EPA, NCI, NIEHS. He serves as a part-time Consultant/Expert Witness in Chemical Toxicology and Chemical Carcinogenesis.

Western Oncology & Hematology Consulting Services
Laramie, Wyoming
112 Satanka Road, 82070


Contact:  Clinton F Merrill, MD
www.westernoncology.com
308-225-3954 Or Toll Free
clinton.merrill@hotmail.com
112 Satanka Road
Laramie, Wyoming 82070

Contact:  Clinton F Merrill, MD
www.westernoncology.com
308-225-3954
clinton.merrill@hotmail.com
Experienced in the diagnosis and treatment of all solid tumors as well as the full range of hematologic malignancies. Special expertise in benign hematology including: anemias, low blood cell counts, iron overload disorders, and bleeding and clotting disorders. I take pride in providing thorough record review, meticulously researched reports reflecting unbiased opinions, and excellent communication skills with the ability to make the complex understandable.
Information:  
Hematology,  Internal Medicine,  Oncology, 


Experienced in the diagnosis and treatment of all solid tumors as well as the full range of hematologic malignancies. Special expertise in benign hematology including: anemias, low blood cell counts, iron overload disorders, and bleeding and clotting disorders. I take pride in providing thorough record review, meticulously researched reports reflecting unbiased opinions, and excellent communication skills with the ability to make the complex understandable.

Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
Wynnewood, Pennsylvania
100 East Lancaster Avenue Suite 222, 19096


Contact:  Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
267-402-0545 Or Toll Free
richard.pestell@gmail.com
100 East Lancaster Avenue Suite 222
Wynnewood, Pennsylvania 19096

Contact:  Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
Richard G. Pestell, MD, PhD, FRACP, FACP, MBA
267-402-0545
richard.pestell@gmail.com

Richard G. Pestell's CV

Strong patent litigation experience. Over 30 years of experience in medicine including oncology. Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Biotechnology Company Founder
Information:  
Intellectual Properties,  Internal Medicine,  Medical Malpractice,  Oncology,  Patents, 


Richard G. Pestell's CV

Strong patent litigation experience. Over 30 years of experience in medicine including oncology. Training include -Massachusetts General Hospital (Fellow) -Harvard Medical School Previous titles include NCI Cancer Center Director for 13 years Lombardi Cancer Center, Georgetown University. Sidney Kimmel Cancer Center, Thomas Jefferson University. Department Chairman of Oncology, Georgetown University. Department Chairman of Cancer Biology, Thomas Jefferson University. Executive Vice President Thomas Jefferson University. Ranked in the world as Highly Cited research scientist in breast cancer (#6), prostate cancer (#2) Recipient of research grants and multiple national awards. Elected Member American Society of Clinical Investigators. Gragnani Endowed Chair Biotechnology Company Founder

Oncology Consulting Services, LLC
Syracuse, Indiana
741 East Northshore Drive, 46567


Contact:  Kenneth L Pennington, MD
www.oncolaw.com
574-355-3333 Or Toll Free
drp@oncolaw.com
741 East Northshore Drive
Syracuse, Indiana 46567

Contact:  Kenneth L Pennington, MD
www.oncolaw.com
574-355-3333
drp@oncolaw.com
Information:  
Oncology,